NSEGeneral Updates6d ago · 25 Aug 2026, 11:29 pm
General Updates
Gujarat Themis Biosyn Limited · GUJTHEM
✦ AI SummaryFundraise
Gujarat Themis Biosyn Limited has informed the Exchange about General Updates - Outcome of Board meeting relating to QIP Issue. The company has approved the preliminary placement document, authorized the opening of the proposed Issue of Equity Shares to eligible QIBs, and approved the floor price for the QIP.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gujarat Themis Biosyn Limited has informed the Exchange about General Updates - Outcome of Board meeting relating to QIP Issue.
Attachments (1)
📄pdf
Download →
GUJARATTHEMIS_25082026232939_SEOutcome25082026.pdf
View document text
GUJARAT THEMIS
BIOSYN LIMITED
CIN: L24230GJ1981PLC004878
REGD. OFFICE & FACTORY: 69/C GIDC INDUSTRIAL ESTATE,
VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA
TE: 0260-2430027 / 2400639
E-mail:hrm@gtbl.in.net
25th August, 2026
The Manager The General Manager
Listing Department Department of Corporate Services
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Dalal Street
Bandra Kurla Complex Mumbai - 400 001
Bandra East
Mumbai - 400 051
Symbol: GUJTHEM Scrip Code: 506879
Dear Sir/Madam,
Re: Qualified institutions placement (“QIP or “Issue”) of equity shares of face value of
₹ 1 each (the “Equity Shares”) to qualified institutional buyers (the “QIBs”)
Sub: Outcome of the meeting of the Board of Directors
We wish to inform you that pursuant to the approval of the board of directors of the Company at
its meeting held on 25th August, 2026 and approval of the shareholders of the Company by way
of a special resolution passed on 22nd August, 2026, the Board of Directors of the Company, in
its meeting held today i.e. 25th August, 2026, has inter alia considered and approved the following:
(i) approval and adoption of the preliminary placement document dated 25th August, 2026,
and the draft of application form, in connection with the QIP;
(ii) authorizing the opening of the proposed Issue of such number of Equity Shares to eligible
QIBs through a qualified institutions placement under Chapter VI of the Securities and
Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations,
2018, as amended (“SEBI ICDR Regulations”) and Section 42 and 62 (1) (c) of the
Companies Act, 2013, read with Rule 14 of the Companies (Prospectus and Allotment of
Securities) Rules, 2014, each as amended today, i.e. on 25th August, 2026; and
(iii) approved the floor price for the QIP, as prescribed under SEBI ICDR Regulations.
We further wish to inform you that the ‘Relevant Date’ for the purpose of the QIP, in terms of the
SEBI ICDR Regulations is 25th August, 2026 and accordingly the floor price in respect of the QIP,
based on the pricing formula as prescribed under Regulation 176(1) of the SEBI ICDR
Regulations is ₹ 372.57 per Equity Share. Pursuant to Regulation 176(1) of the SEBI ICDR
Regulations and special resolution of the Shareholders dated 22nd August, 2026, the Company
MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104
Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019 E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in
GUJARAT THEMIS
BIOSYN LIMITED
CIN: L24230GJ1981PLC004878
REGD. OFFICE & FACTORY: 69/C GIDC INDUSTRIAL ESTATE,
VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA
TE: 0260-2430027 / 2400639
E-mail:hrm@gtbl.in.net
may, at its discretion, offer a discount of not more than 5% (five percent) on the floor price so
calculated for the QIP.
The Board meeting commenced at 10:15 p.m. and the meeting was concluded at 11:15 p.m.
In relation to the QIP, we are filing the preliminary placement document dated 25th August, 2026
with your office. Copy of this intimation is also being made available on the website of the
Company at www.gtbl.in.
Further, as per Company’s Code of Conduct for Regulating, Monitoring and Reporting to regulate,
monitor and report trading by Designated Persons (“Code”), the trading window for dealing in the
securities of the Company is closed from 25th August, 2026 till 48 hours after determination of
Issue price for all ‘Designated Persons’ as defined in the Code.
We request you to take the above on record pursuant to compliance under SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 as amended.
Thanking you,
Yours faithfully
For Gujarat Themis Biosyn Limited
Vineet Gawankar
Company Secretary & Compliance Officer
MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104
Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019 E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in